-transparent.png){kind=logo}
The isolation and characterisation of a monoclonal antibody (2H9), selected for reactivity against murine teratocarcinoma stem cells, is described. This antibody recognizes one major glycoprotein on the surface of embryonal carcinoma (EC) cells but detects multiple glycoprotein species on various murine or human derived cell types. The binding of the antibody to cells is abolished by treatment with periodate or neuraminidase. These results suggest that 2H9 antibody detects a carbohydrate determinant; this is apparently distinct from other anti-EC reactive monoclonal antibodies and a variety of lectins. These antibodies are mitogenic for a population of lymphocytes in murine spleen. The antibodies recognize numerous cell surface glycoproteins on the surface of the spleen cells.
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
April 1981,
European journal of immunology,
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
November 1984,
Journal of immunology (Baltimore, Md. : 1950),
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
January 1985,
Hybridoma,
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
April 1989,
Journal of immunology (Baltimore, Md. : 1950),
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
March 1988,
British journal of cancer,
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
April 1981,
Proceedings of the National Academy of Sciences of the United States of America,
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
September 1988,
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
January 1982,
Hybridoma,
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
January 1983,
The EMBO journal,
P Stern, and
P Gilbert, and
S Sternberg, and
S Thompson, and
K Chada
December 1990,
Development, growth & differentiation,
